- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00894426
Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease (SYMBOL)
December 2, 2010 updated by: AstraZeneca
Prospective, Observational, Multi-center, Non-interventional Study to Assess Patients Perception in SYmptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease
The aim of this study is to assess the perception of chronic obstructive pulmonary disease (COPD) patients in symptoms related to morning activities.
Also the researchers investigated how to describe the impact of symptoms on sleep quality and how to use the medication in Korea COPD treatments.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Anticipated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Daegu, Korea, Republic of
- Research Site
-
Gyongiju, Korea, Republic of
- Research Site
-
Pohang, Korea, Republic of
- Research Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The inclusion/exclusion criteria are designed to select subjects suffering from severe COPD (according to spirometric classification, GOLD stage III and IV) and in a stable state
Description
Inclusion Criteria:
- COPD outpatients over 45 years old
- Lung function: post-FEV1 < 50%
- Current or ex-smoker > 10 packs per year
- Patients who were not on medication of ISC/FC at least 2 weeks
Exclusion Criteria:
- Ongoing exacerbation of COPD or within the previous 3 months
- History of asthma or allergic rhinitis
- Lung cancer or any other significant respiratory disease such as bronchiectasis, lung fibrosis, interstitial lung disease, tuberculosis, sarcoidosis
- Current participation in an interventional clinical trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
1
Morning Symptoms (+)
|
|
2
Morning Symptoms (-)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To assess the perception of COPD Patients in symptoms related to morning activities
Time Frame: At baseline and last visit (after 2~3 months)
|
At baseline and last visit (after 2~3 months)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To assess the patient's perception of the variability of symptoms
Time Frame: At baseline and last visit (after 2~3 months)
|
At baseline and last visit (after 2~3 months)
|
|
To describe how patients use their COPD treatments
Time Frame: At baseline and last visit (after 2~3 months)
|
At baseline and last visit (after 2~3 months)
|
|
To investigate factors that may influence the patient's perception of symptom variability (such as patient characteristics, COPD treatments, co morbidities, etc…)
Time Frame: At baseline and last visit (after 2~3 months)
|
At baseline and last visit (after 2~3 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Joonwoo Bahn, Astrazenca Korea, Medical Department
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
April 28, 2009
First Submitted That Met QC Criteria
May 6, 2009
First Posted (Estimate)
May 7, 2009
Study Record Updates
Last Update Posted (Estimate)
December 3, 2010
Last Update Submitted That Met QC Criteria
December 2, 2010
Last Verified
December 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIS-RKR-DUM-2009/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.